Tarsus Pharmaceuticals: Deal Incluses Upfront Consideration of About $450M, Consisting of $270M in Cash and $180M in Tarsus Common Stk >TARS

Dow Jones2026/08/06 11:18

By:Dow Jones

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Oil rises as risks of prolonged Mideast conflict heighten supply worries

EconomicTimes•2026/09/08 02:03

Bharat Dynamics Started at Hold by Jefferies >541143.BY

Dow Jones•2026/09/08 01:30

Astra Microwave Products Started at Buy by Jefferies >532493.BY

Dow Jones•2026/09/08 01:30

Solar Industries India Started at Buy by Jefferies >532725.BY

Dow Jones•2026/09/08 01:29